coronary artery disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with STEMI undergoing primary percutaneous coronary intervention (PCI) were eligible for this trial if their symptoms lasted <24 h and if they had ST-segment elevation of at least 0.1 mV in two or more extremity leads or at least 0.2 mV in two or more precordial leads.
Exclusion criteria
Exclusion criteria: Exclusion criteria were prior fibrinolysis, cardiogenic shock, pregnancy, participation in another trial, age <18 years, co-morbidity with a limited life expectancy <6 months, and contraindications to CMR at study entry.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| microvascular function; | — |
Secondary
| Measure | Time frame |
|---|---|
| left ventricular function;major adverse cardiovascular events;infarct size; | — |
Countries
China
Contacts
Ji'nan University, Shenzhen Peoples Hospital, Clinical Medical Colleage 2, Dept Cardiology